OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel
Mário Sousa‐Pimenta, Letı́cia M. Estevinho, Agnieszka Szopa, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
Natalia I. Agalakova
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 945-945
Open Access | Times Cited: 13

Targeting chromosomal instability in patients with cancer
Duaa H. Al-Rawi, Emanuele Lettera, Jun Li, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 645-659
Closed Access | Times Cited: 12

Plasticity in cell migration modes across development, physiology, and disease
Mona Pourjafar, Vijay Tiwari
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 10

Dual pH/redox-responsive hyperbranched polymeric nanocarriers with TME-trigger size shrinkage and charge reversible ability for amplified chemotherapy of breast cancer
Fahimeh Badparvar, Ahmad Poursattar Marjani, Roya Salehi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Piperlongumine and its derivatives against cancer: A recent update and future prospective
Shasank S. Swain, Sanjeeb Kumar Sahoo
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 5

Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress
Sajad Dekamin, Mehdi Ghasemi, Ahmad Reza Dehpour, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 1049-1060
Closed Access | Times Cited: 4

Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 4

Role of Folate Receptor and CD44 in Targeting of Docetaxel and Paclitaxel Fabricated Conjugates for Efficient Cancer Therapy
Amol Tatode, Pranav Agrawal, Jayshree Taksande, et al.
Journal of Medicine Surgery and Public Health (2024), pp. 100163-100163
Open Access | Times Cited: 4

Drugs from poisonous plants: Ethnopharmacological relevance to modern perspectives
Bhagya Lakhmi Rajbongshi, Ashis K. Mukherjee
Toxicon X (2025), pp. 100215-100215
Open Access

Incubator-integrated electrochemical analysis platform for cell-based studies
Fatma Kurul, Meryem Beyza Avci, H. Bertan Acar, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access

Mechanism of Action and Interaction of Garlic Extract and Established Therapeutics in Prostate Cancer
Marco Hoffmann, J. D. SAUER, Marius Book, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1777-1777
Open Access

A comprehensive review on the latest advances of dimeric anticancer prodrugs
Zhila Imani, Ebrahim Saeedian Moghadam, Zahra Imani, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access

Dicentrine and its N-oxide derivatives induces apoptotic and necrotic cell death in prostate cancer cell lines
Roberto F. Machado, Daniela C. Tristão, Natália Meneses Araújo, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100257-100257
Open Access

Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies
Giovanni Luca Beretta, Giuliana Cassinelli, Giacomina Rossi, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101223-101223
Open Access

In vitro anticancer activity of encapsulated polymeric nanoparticles of cabazitaxel and ruthenium compound NAMI-A drugs in the treatment of esophogeal cancer
Jiani Zhang, Xiaoli Mei, Erliang Zheng, et al.
Journal of materials research/Pratt's guide to venture capital sources (2025)
Closed Access

The Role of Terpenes in Cancer Management
Shinjini Sen, Banashree Bondhopadhyay
IGI Global eBooks (2025), pp. 217-234
Closed Access

Attenuation of Paclitaxel-induced toxicities by polyphenolic natural compound rutin through inhibition of apoptosis and activation of NRF2/ARE signaling pathways
Souradeep Biswas, Mrinmoyee Mondal, Shampa Pakhira, et al.
Food and Chemical Toxicology (2025), pp. 115408-115408
Closed Access

Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling
Sanober Kafeel, Giuseppina Palmiero, Alessia Salzillo, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 602-602
Open Access

Plant Terpenoids in Combination with Conventional Therapeutics in Colorectal Cancer: A Promising Option
Chengu Niu, Jing Zhang, Patrick Okolo
Current Oncology Reports (2025)
Closed Access

Development of a Prostate-Specific Antigen Targeted Dual Drug Conjugate for Prostate Cancer Therapy
Oluwanifemi Owoseni, Tayo Alex Adekiya, Emmanuel S. Akinboye, et al.
ACS Omega (2025)
Open Access

Exploring the Biomedical Potential of Terpenoid Alkaloids: Sources, Structures, and Activities
Xuyan Wang, Jianzeng Xin, Lili Sun, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 1968-1968
Open Access | Times Cited: 3

Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
Komal Komal, Bibhu Prasad Nanda, L. Singh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9449-9474
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top